A cancer drug target already being investigated in clinical trials turns out to be doing something even more consequential ...
Discovery reshapes understanding of how tumor cells repair broken DNA, pointing toward more precise cancer therapies.
CDT1 inhibits the helicase activity of the MCM complex, thereby suppressing nascent strand synthesis in DNA replication in cultured human cells. This action results in fork collapse and DNA damage, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results